Ethanedioyl dibromide → HCID 58432792, compound

HRID 1640694Notes

Reaction equation

HRID 1640694 reaction equation
[CH3:1][C:2]1[N:7]([C:8]2[CH:13]=[CH:12][CH:11]=[C:10]([C:14]([F:17])([F:16])[F:15])[CH:9]=2)[C:6](=[O:18])[C:5](=O)[NH:4][CH:3]=1.C(Br)(=O)C([Br:23])=O>CN(C=O)C.ClCCCl>[Br:23][C:5]1[C:6](=[O:18])[N:7]([C:8]2[CH:13]=[CH:12][CH:11]=[C:10]([C:14]([F:17])([F:16])[F:15])[CH:9]=2)[C:2]([CH3:1])=[CH:3][N:4]=1

Participants

5

Procedure

6-Methyl-1-[3-(trifluoromethyl)phenyl]-1,4-dihydropyrazine-2,3-dione (0.52 g, 1.92 mmol) and 1,2-dichloroethane (10 ml) were placed in a vial (20 ml). To the resulting suspension was added carefully oxalyl bromide (0.53 ml, 1.24 g, 5.75 mmol). A foam was formed during the addition, and as the foam was settling down the stirring was started. DMF (3 drops) was added and the vial was sealed and the mixture was stirred overnight. Another portion of oxalyl bromide (0.2 ml, 0.46 g, 2.23 mmol) and DMF (3 drops) was added and the reaction was run for another 24 h. The mixture was partitioned between DCM (20 ml) and water (20 ml) and the organic phase was dried. Filtration and evaporation gave a crude product, which was purified on silica, affording 0.59 g (93%) of 3-bromo-6-methyl-1-[3-(trifluoromethyl)phenyl]pyrazin-2(1H)-one.

Workup

  1. customA foam was formed during the addition
  2. customthe vial was sealed
  3. waitthe reaction was run for another 24 h
  4. customThe mixture was partitioned between DCM (20 ml) and water (20 ml)
  5. customthe organic phase was dried
  6. filtrationFiltration and evaporation
  7. customgave a crude product, which
  8. customwas purified on silica

Sources & evidence

ORD record
ord-3d83cc1120bf4238bf880e47ad1adaa7
Source dataset
uspto-grants-2012_02
Patent number
US08114881B2

Reaction notes

Loading…